Syndax Pharmaceuticals Inc Quarterly Current Ratio in % from Q3 2016 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Syndax Pharmaceuticals Inc quarterly Current Ratio history and growth rate from Q3 2016 to Q2 2024.
  • Syndax Pharmaceuticals Inc Current Ratio for the quarter ending June 30, 2024 was 977 %, a 40.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 977 -659 -40.3% Jun 30, 2024
Q1 2024 1.02K -585 -36.4% Mar 31, 2024
Q4 2023 1.2K -292 -19.6% Dec 31, 2023
Q3 2023 1.41K -162 -10.3% Sep 30, 2023
Q2 2023 1.64K +285 +21% Jun 30, 2023
Q1 2023 1.61K +295 +22.5% Mar 31, 2023
Q4 2022 1.49K +241 +19.3% Dec 31, 2022
Q3 2022 1.57K +453 +40.5% Sep 30, 2022
Q2 2022 1.35K +124 +10.1% Jun 30, 2022
Q1 2022 1.31K -19.1 -1.43% Mar 31, 2022
Q4 2021 1.25K +67 +5.66% Dec 31, 2021
Q3 2021 1.12K +291 +35.2% Sep 30, 2021
Q2 2021 1.23K +590 +92.5% Jun 30, 2021
Q1 2021 1.33K +884 +197% Mar 31, 2021
Q4 2020 1.18K +724 +158% Dec 31, 2020
Q3 2020 827 +321 +63.5% Sep 30, 2020
Q2 2020 638 +90.7 +16.6% Jun 30, 2020
Q1 2020 449 -112 -20% Mar 31, 2020
Q4 2019 459 -122 -21% Dec 31, 2019
Q3 2019 506 -151 -23% Sep 30, 2019
Q2 2019 547 -180 -24.7% Jun 30, 2019
Q1 2019 560 -314 -35.9% Mar 31, 2019
Q4 2018 582 -349 -37.5% Dec 31, 2018
Q3 2018 657 -328 -33.3% Sep 30, 2018
Q2 2018 727 -361 -33.2% Jun 30, 2018
Q1 2018 875 -340 -28% Mar 31, 2018
Q4 2017 931 -546 -37% Dec 31, 2017
Q3 2017 985 -713 -42% Sep 30, 2017
Q2 2017 1.09K Jun 30, 2017
Q1 2017 1.21K Mar 31, 2017
Q4 2016 1.48K Dec 31, 2016
Q3 2016 1.7K Sep 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.